Document download

Please enter your email address to download the document - once you’ve submitted this you will be able to download any documents from the website in this session.

Not downloaded documents before? Please click here

Please supply the following information to download the document - once you've supplied this information you will be able to download any documents from the website in this session and on subsequent visits you will just need to enter your email address.

Privacy Policy Downloaded documents before? Please click here

The Oliver Wight EAME website uses cookies by continuing to browse the website you are agreeing to our use of cookies. Further information

Healing Healthcare. Transforming the drug life cycle

Healing Healthcare. Transforming the drug life cycle

Healing Healthcare. Transforming the drug life cycle
(PDF Document (6.51MB))

Gary Connors, Oliver Wight Associate

Big pharmaceutical organisations will tell you that innovation is at the heart of what they do. Whether they aspire to helping people "Do More, Live Longer, Feel Better" or are striving to "Save and Improve Lives" they all rely on robust research and disciplined development processes to bring new drugs to market in a cost­effective way. On average, the industry introduces 30 new drugs per year at a total annual cost of nearly $100bn. The lead-time from discovery to launch of each of these drugs is usually over 10 years and the number of failed candidates for each successful launch is over 25,000, which poses the question, what should big pharmaceutical companies be doing differently in the 21st century to improve their rate of success?

Download

Back to Books